[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Amphastar Pharma (AMPH)

Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
1 Healthcare Stock to Consider Right Now and 2 We Brush Off

1 Healthcare Stock to Consider Right Now and 2 We Brush Off

AMPH : 19.64 (-2.29%)
WAT : 379.29 (+0.31%)
RDNT : 68.75 (+4.77%)
Amphastar Pharmaceuticals Sees Generic Atrovent Fueling 2026 Growth Despite BAQSIMI Drag

Amphastar Pharmaceuticals (NASDAQ:AMPH) executives told investors at the Jefferies Healthcare Conference that the company is maintaining expectations for mid- to high-single-digit revenue growth in 2026,...

AMPH : 19.64 (-2.29%)
3 Stocks Under $50 with Open Questions

3 Stocks Under $50 with Open Questions

GCO : 33.16 (-2.18%)
AMPH : 19.64 (-2.29%)
SNDR : 35.80 (-1.65%)
Why Amphastar Pharmaceuticals (AMPH) Stock Is Trading Lower Today

Why Amphastar Pharmaceuticals (AMPH) Stock Is Trading Lower Today

AMPH : 19.64 (-2.29%)
Amphastar Pharmaceuticals Tackles BAQSIMI Discount Pressure, Keeps Sales Outlook

Amphastar Pharmaceuticals (NASDAQ:AMPH) executives said the company is taking steps to address rebate and discounting pressure on BAQSIMI while maintaining its full-year revenue outlook, according to remarks...

AMPH : 19.64 (-2.29%)
The 5 Most Interesting Analyst Questions From Amphastar Pharmaceuticals’s Q1 Earnings Call

The 5 Most Interesting Analyst Questions From Amphastar Pharmaceuticals’s Q1 Earnings Call

AMPH : 19.64 (-2.29%)
Q1 Earnings Roundup: Amphastar Pharmaceuticals (NASDAQ:AMPH) And The Rest Of The Pharmaceuticals Segment

Q1 Earnings Roundup: Amphastar Pharmaceuticals (NASDAQ:AMPH) And The Rest Of The Pharmaceuticals Segment

AMPH : 19.64 (-2.29%)
Amphastar Pharmaceuticals Q1 Earnings Call Highlights

Amphastar Pharmaceuticals (NASDAQ:AMPH) reported first-quarter 2026 net revenues of approximately $171.2 million, up slightly from $170.5 million in the prior-year period, as recently launched products...

AMPH : 19.64 (-2.29%)
Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q1 CY2026 Sales Expectations, Stock Drops

Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q1 CY2026 Sales Expectations, Stock Drops

AMPH : 19.64 (-2.29%)
Amphastar: Q1 Earnings Snapshot

Amphastar: Q1 Earnings Snapshot

AMPH : 19.64 (-2.29%)

Barchart Exclusives

RIVN Stock Pops as Rivian Raises Delivery Outlook
Rivian stock rallies on better-than-expected Q2 deliveries and raised full-year outlook. Canaccord reiterated its bullish view on RIVN shares today. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.